Clinical Trials for Cancer Type: Other Hematopoietic

5 Open Trials. Phone:(877.827.8839)
Protocol No. Title Status
UCI-14-03 Role of inflammation in the pathogenesis of myeloproliferative neoplasm Open
UCI-14-89 [BIOREPOSITORY] Hematologic Malignancies Biorepository for human research Open
UCI-14-93 UCReliance#1415_Phase 1b Trial of the Combination of Ibrutinib and Azacitidine for the Treatment of Higher Risk Myelodysplastic Syndromes in Previously Treated Patients or in Untreated Patients Unfit for or Who Refuse Intense Therapy Open
UCI-16-95 A Phase 1b/2 Dose-Escalation and Cohort-Expansion Study of a Non-Covalent, Reversible Bruton's Tyrosine Kinase Inhibitor, SNS 062, in Patients With B-Lymphoid Malignancies Open
UCI-17-15 The NUTRIENT Trial (NUTRitional Intervention among myEloproliferative Neoplasms Trial): Focus Groups to Refine a Nutritional Intervention Open